1,3,4-thiadiazole has been researched along with Disease Models, Animal in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Dujaili, AH; Al-Qirim, TM; Al-Samad, LA; Hamadneh, IM; Hamadneh, LA; Hasan, M; Hikmat, SJ; Sabbah, DA | 1 |
Ahuja, P; Arya, SK; Malik, S; Siddiqui, N | 1 |
Brahmkshatriya, PS; Dinda, SC; Panda, JR; Ravi Kumar, BV; Sahoo, BM | 1 |
da Silva, CC; Desoti, VC; Falzirolli, H; Lazarin-Bidóia, D; Martins, SC; Nakamura, CV; Silva, SO; Ueda-Nakamura, T | 1 |
Forouzannia, SK; Pourrajab, F; Tabatabaee, SA | 1 |
Aguilar, N; Armengol, C; Casals, D; Córdoba, M; Domenech, T; Domínguez, M; Esteban, L; Godessart, N; Grima, PM; López, M; Mir, M; Moreno, I; Sabaté, M; Segarra, V; Tarrasón, G; Vilella, D | 1 |
6 other study(ies) available for 1,3,4-thiadiazole and Disease Models, Animal
Article | Year |
---|---|
Hypolipidemic effect of novel 2,5-bis(4-hydroxybenzylidenamino)-1,3,4-thiadiazole as potential peroxisome proliferation-activated receptor-α agonist in acute hyperlipidemic rat model.
Topics: Acute Disease; Animals; Disease Models, Animal; Gene Expression Regulation; Hyperlipidemias; Hypolipidemic Agents; Male; PPAR alpha; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiadiazoles | 2019 |
Design of benzothiazole-1,3,4-thiadiazole conjugates: synthesis and anticonvulsant evaluation.
Topics: Animals; Anticonvulsants; Benzothiazoles; Brain; Disease Models, Animal; Drug Design; Electroshock; gamma-Aminobutyric Acid; Liver; Male; Mice; Molecular Structure; Pentylenetetrazole; Rats, Wistar; Seizures; Structure-Activity Relationship; Thiadiazoles | 2013 |
Molecular docking study, green synthesis and pharmacological evaluation of 1,3,4-thiadiazole derivatives as potential antiepileptic agents.
Topics: Animals; Anticonvulsants; Binding Sites; Disease Models, Animal; Electroshock; Female; Green Chemistry Technology; Male; Microwaves; Molecular Docking Simulation; Motor Activity; Protein Structure, Tertiary; Rats; Seizures; Sodium Channels; Structure-Activity Relationship; Thiadiazoles; Toxicity Tests | 2013 |
1,3,4-Thiadiazole derivatives of R-(+)-limonene benzaldehyde-thiosemicarbazones cause death in Trypanosoma cruzi through oxidative stress.
Topics: Animals; Antiprotozoal Agents; Benzaldehydes; Chagas Disease; Cyclohexenes; Disease Models, Animal; Female; Humans; Limonene; Mice, Inbred BALB C; Molecular Structure; Oxidative Stress; Parasite Load; Parasitemia; Terpenes; Thiadiazoles; Thiosemicarbazones; Treatment Outcome; Trypanosoma cruzi | 2016 |
Novel immunomodulatory function of 1,3,4-thiadiazole derivatives with leishmanicidal activity.
Topics: Animals; Antiprotozoal Agents; Cytokines; Disease Models, Animal; Histocytochemistry; Immunologic Factors; Injections, Intraperitoneal; Leishmaniasis; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Skin; Spleen; Thiadiazoles; Treatment Outcome | 2012 |
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists.
Topics: Administration, Oral; Animals; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Encephalomyelitis, Autoimmune, Experimental; Lymphopenia; Models, Molecular; Molecular Structure; Rats; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; Structure-Activity Relationship; Thiadiazoles | 2012 |